Top Markets
#1 DogBull DogBull +55.75%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +28.67%
#3 DigiByte DigiByte +18.56%
#4 OriginTrail OriginTrail +16.95%
#5 Ethena Staked ENA Ethena Staked ENA +15.58%
#6 Ether.fi Ether.fi +11.05%
#7 Siren Siren +10.95%
#8 MarsCoin MarsCoin +10.44%
#9 龙虾 (Lobster) 龙虾 (Lobster) +9.81%
#10 Purr Purr +9.26%
Coin of the day
DogBull DogBull
Settings
Language
ENGLISH
Currency
USD
Theme
Vikram Thermo (India) Limited Vikram Thermo (India) Limited

Vikram Thermo (India) Limited

VIKRAMTH
Rank in Stocks #21875
Vikram Thermo (India) Ltd. is engaged in the full lifecycle of pharmaceutical... Vikram Thermo (India) Ltd. is engaged in the full lifecycle of pharmaceutical coating polymers and various chemical products, encompassing their initial research, subsequent development, manufacturing, and market distribution. The company conducts its business across two primary geographical areas: India and the rest of the world. Its notable offerings include pharmaceutical-grade polymers and Diphenyl Oxide. This enterprise was established in 1984 by Dhirajlal Karsandas Patel and is headquartered in Ahmedabad, India.
Share Price
$3.15
Last synced: 2026-08-21
Market Cap
$98.80M
Change (1 day)
4.98%
Change (1 year)
66.56%
Country
IN
Trade Vikram Thermo (India) Limited (VIKRAMTH)

Category

Healthcare
Revenue for Vikram Thermo (India) Limited (VIKRAMTH)
Revenue in Aug 2026 TTM: 0
According to Vikram Thermo (India) Limited latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Vikram Thermo (India) Limited from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $830.81M -
US
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT